Metastatic tumour burden was induced by intrasplenic injection of KPC-derived pancreatic cancer cells isolated from the genetically engineered mouse model of PDAC (KrasG12D; Trp53R172H; Pdx1-Cre)24. This evidence concerns the gene PDX1 and pancreatic neoplasm.